| Date Filed | Type | Description |
| 08/01/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 07/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/21/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/21/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 07/07/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
| 06/02/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/26/2022 |
SD
| Form SD - Specialized disclosure report: |
| 05/23/2022 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 05/06/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/05/2022 |
8-K
| Quarterly results |
| 04/28/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/18/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/18/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 02/25/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/24/2022 |
8-K
| Quarterly results |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.9% stake in Natus Medical Inc. |
| 02/02/2022 |
SC 13G/A
| VICTORY CAPITAL MANAGEMENT INC reports a 717% stake in Natus Medical Inc. |
| 01/27/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2022 |
SC 13G/A
| BlackRock Inc. reports a 19.2% stake in NATUS MEDICAL INC |
| 01/19/2022 |
SC 13G
| Allspring Global Investments Holdings, LLC reports a 5.3% stake in NATUS MEDICAL |
| 01/10/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
|